0001567619-23-007441.txt : 20231013 0001567619-23-007441.hdr.sgml : 20231013 20231012200541 ACCESSION NUMBER: 0001567619-23-007441 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20231013 DATE AS OF CHANGE: 20231012 EFFECTIVENESS DATE: 20231013 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Andira Medicine Inc. CENTRAL INDEX KEY: 0001916630 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-494636 FILM NUMBER: 231323660 BUSINESS ADDRESS: STREET 1: 113-735 15TH STREET WEST CITY: NORTH VANCOUVER STATE: A1 ZIP: V7M 0B8 BUSINESS PHONE: 604-335-6348 MAIL ADDRESS: STREET 1: 113-735 15TH STREET WEST CITY: NORTH VANCOUVER STATE: A1 ZIP: V7M 0B8 D 1 primary_doc.xml X0708 D LIVE 0001916630 Andira Medicine Inc. 507-725 Marine Drive NORTH VANCOUVER A1 BRITISH COLUMBIA, CANADA V7M 0G2 604-335-6348 BRITISH COLUMBIA, CANADA None None Corporation true Dana Lambert 507-725 Marine Drive North Vancouver A1 BRITISH COLUMBIA, CANADA V7M 0G2 Executive Officer Director Ethan Russo 507-725 Marine Drive North Vancouver A1 BRITISH COLUMBIA, CANADA V7M 0G2 Director Michael Stuart Wall 507-725 Marine Drive North Vancouver A1 BRITISH COLUMBIA, CANADA V7M 0G2 Director Ammad Shorbaji 507-725 Marine Drive North Vancouver A1 BRITISH COLUMBIA, CANADA V7M 0G2 Executive Officer Janette Lyons 507-725 Marine Drive North Vancouver A1 BRITISH COLUMBIA, CANADA V7M 0G2 Executive Officer Other Decline to Disclose 06c false 2023-09-28 false true true true false 0 US Capital Global Securities LLC 169544 None None 1 Ferry Building Suite 201 San Francisco CA CALIFORNIA 94111 CA CALIFORNIA CO COLORADO CT CONNECTICUT DC DISTRICT OF COLUMBIA FL FLORIDA KY KENTUCKY LA LOUISIANA MD MARYLAND NY NEW YORK TX TEXAS WI WISCONSIN false 5396002 212008 5183994 13(b): Not all sales are for cash. 13(c): Includes value of warrants. false 2 12000 0 Plus warrants having a value of approximately $12,006. 0 false Andira Medicine Inc. /s/ Dana Lambert Dana Lambert Chief Executive Officer 2023-10-12